Trials / Conditions / Recurrent Paranasal Sinus Squamous Cell Carcinoma
Recurrent Paranasal Sinus Squamous Cell Carcinoma
5 registered clinical trials studyying Recurrent Paranasal Sinus Squamous Cell Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squ NCT07156227 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058 | Emory University | N/A |
| Recruiting | Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, NCT06636734 | Emory University | Phase 2 |
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Tr NCT04576091 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Can NCT03032250 | Wake Forest University Health Sciences | N/A |